You can buy or sell FREQ and other stocks, options, ETFs, and crypto commission-free!
Frequency Therapeutics, Inc. engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. Read More The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.
52 Week High
52 Week Low
— per share
Expected Nov 16, Pre-Market